| 參考文獻 |
1.Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA: a cancer journal for clinicians 2011, 61(2):69-90.
2.Wang B-Y, Hung J-J, Jeng W-J, Hsu W-H, Hsieh C-C, Huang M-H, Huang B-S, Liu J-S, Wu Y-C: Surgical Outcomes in Resected Non-small Cell Lung Cancer≤ 1 cm in Diameter. Journal of the Chinese Medical Association 2010, 73(6):308-313.
3.Sanchez‐Palencia A, Gomez‐Morales M, Gomez‐Capilla JA, Pedraza V, Boyero L, Rosell R, Fárez‐Vidal M: Gene expression profiling reveals novel biomarkers in nonsmall cell lung cancer. International Journal of Cancer 2011, 129(2):355-364.
4.Lu T-P, Tsai M-H, Lee J-M, Hsu C-P, Chen P-C, Lin C-W, Shih J-Y, Yang P-C, Hsiao CK, Lai L-C: Identification of a Novel Biomarker, SEMA5A, for Non–Small Cell Lung Carcinoma in Nonsmoking Women. Cancer Epidemiology Biomarkers & Prevention 2010, 19(10):2590-2597.
5.Minna JD, Gazdar AF, Sprang SR, Herz J: A bull′s eye for targeted lung cancer therapy. Science 2004, 304(5676):1458-1461.
6.Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proceedings of the National Academy of Sciences 2001, 98(24):13790-13795.
7.Einhorn LH: First-Line Chemotherapy for Non–Small-Cell Lung Cancer: Is There a Superior Regimen Based on Histology? Journal of Clinical Oncology 2008, 26(21):3485-3486.
8.Brown PO, Botstein D: Exploring the new world of the genome with DNA microarrays. Nature genetics 1999, 21:33-37.
9.Su L-J, Chang C-W, Wu Y-C, Chen K-C, Lin C-J, Liang S-C, Lin C-H, Whang-Peng J, Hsu S-L, Chen C-H: Selection of DDX5 as a novel internal control for Q-RT-PCR from microarray data using a block bootstrap re-sampling scheme. BMC genomics 2007, 8(1):140.
10.Kuner R, Muley T, Meister M, Ruschhaupt M, Buness A, Xu EC, Schnabel P, Warth A, Poustka A, Sültmann H: Global gene expression analysis reveals specific patterns of cell junctions in non-small cell lung cancer subtypes. Lung cancer 2009, 63(1):32-38.
11.Shi W, Banerjee A, Ritchie ME, Gerondakis S, Smyth GK: Illumina WG-6 BeadChip strips should be normalized separately. BMC bioinformatics 2009, 10(1):372.
12.Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB: Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis. Modern Pathology 2013.
13.de Matos LL, Trufelli DC, de Matos MGL, da Silva Pinhal MA: Immunohistochemistry as an important tool in biomarkers detection and clinical practice. Biomarker insights 2010, 5:9.
14.Tarca AL, Lauria M, Unger M, Bilal E, Boue S, Dey KK, Hoeng J, Koeppl H, Martin F, Meyer P: Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the improver diagnostic signature challenge. Bioinformatics 2013, 29(22):2892-2899.
15.Rousseaux S, Debernardi A, Jacquiau B, Vitte A-L, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon P-Y, Lantuejoul S, Hainaut P: Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers. Science translational medicine 2013, 5(186):186ra166-186ra166.
16.Der SD, Sykes J, Pintilie M, Zhu C-Q, Strumpf D, Liu N, Jurisica I, Shepherd FA, Tsao M-S: Validation of a Histology-Independent Prognostic Gene Signature for Early-Stage, Non–Small-Cell Lung Cancer Including Stage IA Patients. Journal of Thoracic Oncology 2014, 9(1):59-64.
17.Botling J, Edlund K, Lohr M, Hellwig B, Holmberg L, Lambe M, Berglund A, Ekman S, Bergqvist M, Pontén F: Biomarker discovery in Non–Small cell lung cancer: Integrating gene expression profiling, meta-analysis, and tissue microarray validation. Clinical Cancer Research 2013, 19(1):194-204.
18.Xie Y, Xiao G, Coombes KR, Behrens C, Solis LM, Raso G, Girard L, Erickson HS, Roth J, Heymach JV: Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients. Clinical Cancer Research 2011, 17(17):5705-5714.
19.Hou J, Aerts J, Den Hamer B, Van Ijcken W, Den Bakker M, Riegman P, van der Leest C, van der Spek P, Foekens JA, Hoogsteden HC: Gene expression-based classification of non-small cell lung carcinomas and survival prediction. PloS one 2010, 5(4):e10312.
20.Irizarry RA, Hobbs B, Collin F, Beazer‐Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264.
21.Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP: Summaries of Affymetrix GeneChip probe level data. Nucleic acids research 2003, 31(4):e15-e15.
22.Basseres DS, D’Alò F, Yeap BY, Löwenberg EC, Gonzalez DA, Yasuda H, Dayaram T, Kocher ON, Godleski JJ, Richards WG: Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing. Lung cancer 2012, 77(1):31-37.
23.Hamakawa H, Bao Y, Takarada M, Fukuzumi M, Tanioka H: Cytokeratin expression in squamous cell carcinoma of the lung and oral cavity: an immunohistochemical study with possible clinical relevance. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology 1998, 85(4):438-443.
24.Shahdoust M, Hajizadeh E, Mozdarani H, Chehrei A: Finding Genes Discriminating Smokers from Non-smokers by Applying a Growing Self-organizing Clustering Method to Large Airway Epithelium Cell Microarray Data. Asian Pacific Journal of Cancer Prevention 2013, 14(1):111-116. |
[Endnote RIS 格式]
[相關文章]
[文章引用]
[完整記錄]
[館藏目錄]
[檢視]
plurk
funp
live
udn
HD
myshare
netvibes
friend
youpush
delicious
baidu
Google bookmarks
del.icio.us
hemidemi
facebook
twitter
google
reddit